Immune checkpoint inhibitors and timing of administration

被引:0
|
作者
Dizman, Nazli [1 ]
Velazquez, Ana, I [2 ]
Duma, Narjust [3 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06511 USA
[2] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02215 USA
来源
LANCET ONCOLOGY | 2022年 / 23卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E56 / E56
页数:1
相关论文
共 50 条
  • [21] Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma
    Yeung, Cynthia
    Kartolo, Adi
    Tong, Justin
    Hopman, Wilma
    Baetz, Tara
    IMMUNOTHERAPY, 2023, 15 (11) : 819 - 826
  • [22] Immune checkpoint blockade: timing is everything
    Sinicrope, Frank A.
    Turk, Mary Jo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (08) : 1 - 3
  • [23] Immune checkpoint inhibitors and diabetes
    Campbell, Nicola
    Poole, Ruth
    PRACTICAL DIABETES, 2020, 37 (03) : 96 - 100
  • [24] Immune checkpoint inhibitors in cholangiocarcinoma
    Beri, Nina
    IMMUNOTHERAPY, 2023, 15 (07) : 541 - 551
  • [25] Immune checkpoint inhibitors in GBM
    Lee, Eudocia Q.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (01) : 1 - 11
  • [26] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
  • [27] Cardiotoxicity of Immune Checkpoint Inhibitors
    Patel, Rushin P.
    Parikh, Rohan
    Gunturu, Krishna S.
    Tariq, Rana Zouveenoor
    Dani, Sourbha S.
    Ganatra, Sarju
    Nohria, Anju
    CURRENT ONCOLOGY REPORTS, 2021, 23 (07)
  • [28] Immune Checkpoint Inhibitors in Gliomas
    Aaron C. Tan
    Amy B. Heimberger
    Mustafa Khasraw
    Current Oncology Reports, 2017, 19
  • [29] Immune checkpoint inhibitors in malignancy
    Ardolino, Luke
    Joshua, Anthony
    AUSTRALIAN PRESCRIBER, 2019, 42 (02) : 62 - 67
  • [30] Immune checkpoint inhibitors and vasculitis
    Boland, Patrick
    Heath, Jacqueline
    Sandigursky, Sabina
    CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (01) : 53 - 56